• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.13% Nasdaq Down0.93%

    Salix Pharmaceuticals Ltd. (SLXP)

    -NasdaqGS
    127.89 Up 1.59(1.26%) 4:00PM EST
    |After Hours : 129.50 Up 1.61 (1.26%) 5:20PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 354,719   382,000   384,374   257,612  
    Cost of Revenue86,298  104,325  115,566  56,932  
    Gross Profit 268,421   277,675   268,808   200,680  
    Operating Expenses
    Research Development50,837  39,231  52,758  36,241  
    Selling General and Administrative165,622  124,937  195,205  64,230  
    Non Recurring76,549  10,149  4,039  (7,000)
    Others55,040  54,908  54,895  11,226  
    Total Operating Expenses348,048  229,225  306,897  104,697  
    Operating Income or Loss (79,627) 48,450   (38,089) 95,983  
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,737)(23)309  655  
    Earnings Before Interest And Taxes(81,364)48,427  (37,780)96,638  
    Interest Expense43,623  42,442  42,460  15,366  
    Income Before Tax(124,987)5,985  (80,240)81,272  
    Income Tax Expense(36,392)2,707  (36,368)29,010  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(88,595)3,278  (43,872)52,262  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (88,595) 3,278   (43,872) 52,262  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (88,595) 3,278   (43,872) 52,262  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.